Latest Market Expansion News

XRF Scientific has reported record half-year revenue and profit for FY25, driven by robust demand from mining and industrial sectors and strategic acquisitions that bolster its market position.

Biome Australia Limited has reported its first-ever net profit of $433,395 for the half-year ended December 2024, alongside a 47.4% increase in revenue driven by strong sales of its Activated Probiotics.

Baby Bunting has reported a robust first half for FY25, with net profit after tax rising 37% to $4.8 million and sales edging up 2.4%. The company’s strategic initiatives around margin improvement and store expansion underpin a stable outlook for the full year.

Winsome Resources has raised approximately A$7.8 million through a placement to advance its flagship Adina Lithium Project and extend the Renard Option to August 2025, with plans for an additional share purchase plan targeting A$2.5 million.

Australian Bond Exchange Holdings has entered a strategic Liquidity Provision Agreement with ViewTrade Australia, aiming to broaden investor access to OTC securities globally through integrated technology and expanded market channels.

Carbonxt Group Limited has initiated a $2 million Share Purchase Plan following successful capital raises, aiming to bolster its Kentucky activated carbon facility as it nears commercial production.

Vection Technologies has inked a three-year SaaS agreement with Mexican telecom giant Totalplay, marking a strategic push into Latin America with its Enworks XR platform.

Ovanti Limited has secured board approval for its ambitious US market entry plan targeting $500 million in total transaction volumes within two years, focusing on underserved consumers in the Southern States.

Eden Innovations has landed a significant second order from Holcim Ecuador for its EdenCrete® Pz7 concrete additive, underscoring growing global interest in its low-carbon concrete solutions.

The a2 Milk Company posted robust first-half FY25 results, lifting revenue by 10.1% and net profit by 7.6%, while introducing a dividend policy for the first time. Strong English label IMF sales and liquid milk growth underpin an upgraded full-year outlook.

Wellnex Life Limited has locked in A$9 million in conditional commitments to support its proposed dual listing on the London Stock Exchange’s AIM market, alongside launching a 1:1 entitlement offer for existing shareholders.

Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.